(Q34250496)

31 July 2017

title

Inhibition of metastasis in a castration resistant prostate cancer model by the quinoline-3-carboxamide tasquinimod (ABR-215050). (English)

1 reference

31 July 2017

1 reference

Karin Jennbacken

1

1 reference

31 July 2017

Karin Welén

2

1 reference

31 July 2017

Anders Olsson

3

1 reference

31 July 2017

Bengt Axelsson

4

1 reference

31 July 2017

Marie Törngren

5

1 reference

31 July 2017

Jan-Erik Damber

6

1 reference

31 July 2017

Tomas Leanderson

7

1 reference

31 July 2017

publication date

5 October 2011

1 reference

31 July 2017

1 reference

31 July 2017

volume

72

1 reference

31 July 2017

issue

8

1 reference

31 July 2017

page(s)

913-924

1 reference

31 July 2017

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21495

The quinoline-3-carboxamide anti-angiogenic agent, tasquinimod, enhances the anti-prostate cancer efficacy of androgen ablation and taxotere without effecting serum PSA directly in human xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21495

Identification of ABR-215050 as lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21495

The long and winding road for the development of tasquinimod as an oral second-generation quinoline-3-carboxamide antiangiogenic drug for the treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21495

Open-label, clinical phase I studies of tasquinimod in patients with castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21495

Phase II randomized, double-blind, placebo-controlled study of tasquinimod in men with minimally symptomatic metastatic castrate-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21495

Tasquinimod (ABR-215050), a quinoline-3-carboxamide anti-angiogenic agent, modulates the expression of thrombospondin-1 in human prostate tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21495

Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21495

Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21495

The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21495

Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21495

Tumor angiogenesis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21495

Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21495

HIF-1: using two hands to flip the angiogenic switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21495

Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21495

Hypoxia--a key regulatory factor in tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21495

Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21495

Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21495

Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21495

Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21495

The EGF/CSF-1 paracrine invasion loop can be triggered by heregulin beta1 and CXCL12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21495

HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21495

Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21495

Myeloid-derived suppressor cells: linking inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21495

Transition of an androgen-dependent human prostate cancer cell line into an androgen-independent subline is associated with increased angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21495

Prostate cancer progression into androgen independency is associated with alterations in cell adhesion and invasivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21495

The prostatic environment suppresses growth of androgen-independent prostate cancer xenografts: an effect influenced by testosterone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21495

Exploration, normalization, and summaries of high density oligonucleotide array probe level data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21495

Dissemination and growth of cancer cells in metastatic sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21495

Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21495

Linomide suppresses acute experimental autoimmune encephalomyelitis in Lewis rats by counter-acting the imbalance of pro-inflammatory versus anti-inflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21495

Suppression of tumor cell invasion by cyclooxygenase inhibitors is mediated by thrombospondin-1 via the early growth response gene Egr-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21495

A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21495

Knock down of HIF-1alpha in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21495

Involvement of chemokine receptors in breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21495

Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21495

PAUF functions in the metastasis of human pancreatic cancer cells and upregulates CXCR4 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21495

CXCL12-CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21495

Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21495

21 January 2018

Identifiers

DOI

10.1002/PROS.21495

1 reference

release_lrxyjlhdjfdjhlu42bnrnnhwmy

31 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lrxyjlhdjfdjhlu42bnrnnhwmy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference